Physician profile
Dennis Osena
NPI 1639641129
$13,420.17
in general payments reported to CMS, 2019-2025
24 companies · $1,895 in 2025
The $1,895 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,070 · 2022: $7,346 · 2023: $1,506 · 2024: $1,604 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,654 · Consulting Fee: $175 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,654.12 |
| Consulting Fee | $175.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $7,513.50 | 2021-2024 | Senza |
| Saluda Medical Americas, INC. | $1,376.85 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $1,070.49 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Avista Mri |
| Abbott Laboratories | $751.24 | 2022-2025 | Proclaim, Eterna, Octrode |
| Collegium Pharmaceutical, INC. | $668.63 | 2021-2025 | Xtampza |
| Medtronic, INC. | $420.38 | 2022-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Vertos Medical, INC. | $276.16 | 2021-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $273.66 | 2021-2025 | Relistor |
| Electronic Waveform Lab, INC. | $266.94 | 2022-2025 | |
| Relievant Medsystems, INC. | $181.36 | 2021-2023 | Intracept |
| Protega Pharmaceutials INC | $90.79 | 2023-2024 | Roxybond |
| Bioventus LLC | $83.74 | 2024-2025 | Durolane, Gelsyn-3 |
| Biotronik Nro, INC. | $80.98 | 2024 | Prospera |
| Abbvie INC. | $78.28 | 2021-2024 | |
| Nalu Medical, INC. | $76.68 | 2021-2024 | Nalu Neurostimulation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $45.46 | 2021-2022 | |
| Averitas Pharma INC. | $33.05 | 2025 | Qutenza |
| Almatica Pharma LLC | $29.02 | 2023 | Gralise |
| Painteq LLC | $25.95 | 2021 | |
| Spinal Simplicity, LLC | $21.86 | 2022 | |
| Fidia Pharma USA INC. | $19.08 | 2024 | Hymovis |
| Vertex Pharmaceuticals Incorporated | $17.77 | 2025 | |
| Si-Bone, INC. | $14.40 | 2021 | |
| Forte Bio-Pharma LLC | $3.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Osena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.